MP14: Bladder Cancer: Basic Research & Pathophysiology I

Poster Session Moderator(s)

• QL

  Qiang Li, MD,PhD
• 

  Leonardo Reis, MD

  Pontifical Catholic University of Campinas - PUC-Campinas, Brazil

Presentations:

• 1:00 PM – 3:00 PM CST

  MP14-01: Evaluation of a Novel Cystoscopic Cryocatheter for the In Situ Destruction of Bladder Cancer
  

  Poster Presenter: Aaron Edward Katz, MD
• 1:00 PM – 3:00 PM CST

  MP14-02: Development of a porcine model of bladder cancer using the Oncopig
  

  Poster Presenter: Andreas Aulitzky, Jr., MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP14-03: Virtual Monitoring of Bladder Cancer Progression In Mice With Intravesical Contrast Enhanced Magnetic Resonance Imaging (ICE-MRI)
  

  Poster Presenter: Anirban Ganguly, PHD
• 1:00 PM – 3:00 PM CST

  MP14-04: Establishment of blood-based diagnostic markers of urothelial carcinoma using chiral amino acids
  

  Poster Presenter: Atsunari Kawashima, MD – Osaka University
• 1:00 PM – 3:00 PM CST

  MP14-05: Extracellular Vesicle Biomarker Signature Detection Platform for Guiding Cancer Detection and Therapy
  

  Poster Presenter: Thomas Osinski
• 1:00 PM – 3:00 PM CST

  MP14-06: E-liquid Exposure Induces the Release of Pro-Oncogenic Extracellular Vesicles from Bladder Cancer Cells that Promote the Malignant Transformation of Recipient Urothelial Cells
  

  Poster Presenter: Ryan Molony, PhD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP14-07: Development of a Liquid Biopsy Using Extracellular Vesicles to Assess the Systemic T Cell Immune Landscape in Bladder Cancer
  

  Poster Presenter: Karen M. Doersch, MD, PHD – University of Rochester Medical Center
• 1:00 PM – 3:00 PM CST

  MP14-08: Characterizing Variability in Genomic Alterations between Index and Repeat Transurethral Resection Lesions in Non-Muscle Invasive Bladder Cancer
  

  Poster Presenter: Prithvi Murthy, MD – Moffitt Cancer Center
• 1:00 PM – 3:00 PM CST

  MP14-09: Increased NETosis and impaired DNaseI-mediated NET degradation in bladder cancer patients: approach for an in vitro therapeutical restoration
  

  Poster Presenter: Javier Perez Ardavin, Jr., MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP14-10: Enhanced antitumor effect of the combination of Bacille Calmette-Guérin and an immune checkpoint inhibitor in bladder cancer-on-a-chip
  

  Poster Presenter: Jung Hoon Kim
• 1:00 PM – 3:00 PM CST

  MP14-11: Single cell-based immune profiling of the tumor and its immune microenvironment revealed differences between NMIBC and MIBC: implication for immuno-therapy
  

  Poster Presenter: Massimo Lazzeri
• 1:00 PM – 3:00 PM CST

  MP14-12: Modeling immunotherapy resistance of bladder cancer in immunocompetent mice
  

  Poster Presenter: Qiang John Li, MD,PhD
• 1:00 PM – 3:00 PM CST

  MP14-13: Synergistic Antitumor Activity of PI3K Inhibition and Immune Checkpoint Blockade in Bladder Cancer
  

  Poster Presenter: Vincent D. D'andrea, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP14-14: HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway
  

  Poster Presenter: Qiang Lv
• 1:00 PM – 3:00 PM CST

  MP14-15: Macrophages and Regulatory T-Cells as Prognostic Factors in Patients with Urothelial Muscle-Invasive Bladder Cancer
  

  Poster Presenter: Florestan J. Koll, MD (he/him/his) – University Hospital Frankfurt
• 1:00 PM – 3:00 PM CST

  MP14-16: Late cell cycle signatures stratify GEMDOCE responses for BCG-unresponsive non-muscle invasive bladder cancer
  

  Poster Presenter: Andrew Gabrielson, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP14-17: SMARCD1 regulated by microRNA-99a-5p contributes to gemcitabine resistance in bladder cancer via suppression of cellular senescence
  

  Poster Presenter: Junya Arima, MD (he/him/his) – Kagoshima University
• 1:00 PM – 3:00 PM CST

  MP14-18: Modeling bladder cancer in Down Syndrome animals for discovery of novel therapeutics
  

  Poster Presenter: Binh N. Vo, BA – University of Kansas
• 1:00 PM – 3:00 PM CST

  MP14-19: Alterations of insulin signaling and tumor biology in urothelial carcinoma of diabetic and non-diabetic patients
  

  Poster Presenter: Simon D. Walz, MD (he/him/his) – University Hospital Tuebingen, Dept. Urology
• 1:00 PM – 3:00 PM CST

  MP14-20: Latrophilins as Downstream Effectors of the Androgen Receptor Induce Bladder Cancer Progression
  

  Poster Presenter: Takuro Goto, MD